View of Long-term disease control during TAS-102 therapy in the VI line treatment in a 73-year-old mCRC patient. A case report

Return to Article Details Long-term disease control during TAS-102 therapy in the VI line treatment in a 73-year-old mCRC patient. A case report Download Download PDF